USB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
U.S. Bancorp is not a strong buy for a beginner investor with a long-term strategy at this moment. While the company has shown strong financial performance in the latest quarter and has positive long-term growth prospects, the current technical indicators are neutral, and the stock is in a pre-market decline. Additionally, the options data and stock trend analysis suggest potential short-term downside, and there are no strong proprietary trading signals to indicate an immediate buy opportunity.
The MACD is positive and expanding, indicating a bullish trend, but RSI is neutral at 41.811, showing no clear momentum. Moving averages are converging, and the stock is trading near its pivot level of 51.605. Key support is at 50.627, and resistance is at 52.583. Overall, the technical indicators are mixed and do not strongly support a buy decision.
Hedge funds are significantly increasing their positions in the stock, with a 128.97% increase in buying activity last quarter.
The company has shown strong financial performance in Q4 2025, with revenue up 4.34% YoY, net income up 24.29% YoY, and EPS up 24.75% YoY.
Analysts have highlighted positive operating leverage and a constructive tone from management for the full year ahead.
The stock trend analysis indicates an 80% chance of a -1.74% decline in the next day, -3.07% in the next week, and -5.51% in the next month.
Broader macroeconomic concerns, including the ongoing war in Iran and its impact on global markets, could weigh on sentiment for bank stocks.
Pre-market price is down 0.37%, and the S&P 500 is also down 0.51%, indicating a weak market environment.
In Q4 2025, U.S. Bancorp reported a revenue increase of 4.34% YoY to $6.487 billion, net income growth of 24.29% YoY to $1.965 billion, and EPS growth of 24.75% YoY to $1.26. These results demonstrate strong profitability and growth trends.
Analysts are generally positive on U.S. Bancorp, with several firms maintaining Buy ratings and price targets ranging from $55 to $66. However, some analysts have expressed concerns about weaker net interest margin expansion and in-line loan growth relative to peers, which could limit EPS growth.
